| Long-term results of the FOLL05 trial comparing R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage symptomatic follicular lymphoma S Luminari, A Ferrari, M Manni, A Dondi, A Chiarenza, F Merli, C Rusconi, ... J Clin Oncol 36 (7), 689-696, 2018 | 136 | 2018 |
| Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project CP Fox, M Civallero, YH Ko, M Manni, T Skrypets, S Pileri, SJ Kim, ... The Lancet Haematology 7 (4), e284-e294, 2020 | 115 | 2020 |
| The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project M Bellei, FM Foss, AR Shustov, SM Horwitz, L Marcheselli, WS Kim, ... Haematologica 103 (7), 1191, 2018 | 109 | 2018 |
| Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis M Federico, MDC Barrigón, L Marcheselli, V Tarantino, M Manni, ... The Lancet Haematology 5 (8), e359-e367, 2018 | 106 | 2018 |
| Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project RH Advani, T Skrypets, M Civallero, MA Spinner, M Manni, WS Kim, ... Blood 138 (3), 213-220, 2021 | 68 | 2021 |
| Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network M Federico, M Bellei, L Marcheselli, M Schwartz, M Manni, V Tarantino, ... British journal of haematology 181 (6), 760-769, 2018 | 59 | 2018 |
| Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 … S Luminari, S Galimberti, A Versari, I Biasoli, A Anastasia, C Rusconi, ... Haematologica 101 (2), e66, 2016 | 45 | 2016 |
| Response-adapted postinduction strategy in patients with advanced-stage follicular lymphoma: The FOLL12 study S Luminari, M Manni, S Galimberti, A Versari, A Tucci, C Boccomini, ... Journal of Clinical Oncology 40 (7), 729-739, 2022 | 44 | 2022 |
| ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project A Shustov, ME Cabrera, M Civallero, M Bellei, YH Ko, M Manni, ... Blood Advances 5 (3), 640-648, 2021 | 32 | 2021 |
| Response oriented maintenance therapy in advanced follicular lymphoma. Results of the interim analysis of the foll12 trial conducted by the Fondazione Italiana Linfomi. M Federico, D Mannina, A Versari, S Ferrero, L Marcheselli, C Boccomini, ... Hematological Oncology 37, 153-154, 2019 | 23 | 2019 |
| International T-cell Project Network. The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective M Bellei, FM Foss, AR Shustov, SM Horwitz, L Marcheselli, WS Kim, ... International T-Cell Project. Haematologica 103 (7), 1191-7, 2018 | 13 | 2018 |
| Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma S Alonso-Álvarez, M Manni, S Montoto, C Sarkozy, F Morschhauser, ... European Journal of Cancer 157, 132-139, 2021 | 7 | 2021 |
| T cell Project Network. Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network M Federico, M Bellei, L Marcheselli, M Schwartz, M Manni, V Tarantino, ... Br J Haematol 181 (6), 760-769, 2018 | 7 | 2018 |
| Outcome of patients with gamma delta T cell lymphomas: analysis of 1429 cases registered in the prospective t-cell project FM Foss, SM Horwitz, M Bellei, M Manni, V Tarantino, AR Shustov, ... Blood 130, 1512, 2017 | 5 | 2017 |
| POD24 and CR30 are promising surrogate endpoints for assessing the outcome of patients with advanced stage follicular lymphoma enrolled in the FOLL05 trial by FIL S Luminari, L Marcheselli, M Manni, A Anastasia, U Vitolo, A Chiarenza, ... Hematol Oncol 35 (suppl 2), 228-229, 2017 | 4 | 2017 |
| Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with … F Massaro, Y Stepanishyna, M Manni, S Luminari, S Galimberti, ... British Journal of Haematology 192 (6), 1011-1014, 2021 | 3 | 2021 |
| Subtypes of mature T and NK cell lymphomas according to 2016 who classification. Preliminary report of the international prospective T-cell project 2.0 M Federico, CS Chiattone, HM Prince, A Pavlovsky, M Manni, M Civallero, ... Hematological Oncology, 307-307, 2021 | 3 | 2021 |
| The T cell project 2.0: the more we register, the more we learn M Federico, M Manni, M Civallero, T Skrypets Hematological Oncology 37, 164-165, 2019 | 3 | 2019 |
| LONG TERM RESULTS OF THE FOLL05 RANDOMIZED STUDY COMPARING R‐CVP WITH R‐CHOP AND R‐FM AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA. A FIL STUDY S Luminari, V Tarantino, A Anastasia, C Boccomini, A Chiarenza, ... Hematological Oncology 35, 34-34, 2017 | 3 | 2017 |
| Response adapted post induction therapy in follicular lymphoma: updated results of the FOLL12 trial by the Fondazione Italiana Linfomi (FIL) S Luminari, S Galimberti, A Versari, A Tucci, C Boccomini, L Farina, F Zaja, ... Hematological Oncology 39, 2021 | 2 | 2021 |
